U.S. flag

An official website of the United States government

NM_019109.5(ALG1):c.773C>T (p.Ser258Leu) AND Congenital disorder of glycosylation

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 26, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000606536.13

Allele description [Variation Report for NM_019109.5(ALG1):c.773C>T (p.Ser258Leu)]

NM_019109.5(ALG1):c.773C>T (p.Ser258Leu)

Gene:
ALG1:ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_019109.5(ALG1):c.773C>T (p.Ser258Leu)
Other names:
S258L
HGVS:
  • NC_000016.10:g.5078789C>T
  • NG_009202.1:g.11981C>T
  • NM_001330504.2:c.440C>T
  • NM_019109.5:c.773C>TMANE SELECT
  • NP_001317433.1:p.Ser147Leu
  • NP_061982.3:p.Ser258Leu
  • NP_061982.3:p.Ser258Leu
  • NC_000016.9:g.5128790C>T
  • NM_019109.5:c.773C>T
  • Q9BT22:p.Ser258Leu
Protein change:
S147L; SER258LEU
Links:
UniProtKB: Q9BT22#VAR_023365; OMIM: 605907.0001; dbSNP: rs28939378
NCBI 1000 Genomes Browser:
rs28939378
Molecular consequence:
  • NM_001330504.2:c.440C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_019109.5:c.773C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Congenital disorder of glycosylation (CDG)
Synonyms:
Carbohydrate-deficient glycoprotein syndrome; Congenital disorders of glycosylation
Identifiers:
MONDO: MONDO:0015286; MedGen: C0282577; Orphanet: 137

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000731828Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Pathogenic
(Sep 26, 2017)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

SCV000993477University of Washington Center for Mendelian Genomics, University of Washington
no assertion criteria provided
Likely pathogenic
(May 25, 2017)
unknownresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing
not providedunknownyesnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.

Grubenmann CE, Frank CG, Hülsmeier AJ, Schollen E, Matthijs G, Mayatepek E, Berger EG, Aebi M, Hennet T.

Hum Mol Genet. 2004 Mar 1;13(5):535-42. Epub 2004 Jan 6.

PubMed [citation]
PMID:
14709599

Congenital nephrotic syndrome in an infant with ALG1-congenital disorder of glycosylation.

Harshman LA, Ng BG, Freeze HH, Trapane P, Dolezal A, Brophy PD, Brumbaugh JE.

Pediatr Int. 2016 Aug;58(8):785-8. doi: 10.1111/ped.12988. Epub 2016 Jun 21.

PubMed [citation]
PMID:
27325525
PMCID:
PMC4996748
See all PubMed Citations (9)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000731828.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (9)

Description

The p.Ser258Leu variant in ALG1 has been reported in at least 10 homozygous and 14 compound heterozygous individuals with a congenital disorder of glycosylation (Grubenmann 2004, Schwarz 2004, Kranz 2004, Harshman 2016, Ng 2016, Park 2016, Barba 2016, and Bowling 2017), and has also been reported in ClinVar (Variation ID#4724). In vitro functional studies provide evidence that the p.Ser258ZLeu var iant impacts the protein (Grubenmann 2004, Schwarz 2004, Kranz 2004, and Ng 2016 ). This variant has been identified in 0.05% (67/126078) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; d bSNP rs28939378). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency . In summary, although additional studies are required to fully establish its c linical significance, the p.Ser258Leu variant is pathogenic for congenital disor ders of glycosylation in an autosomal recessive manner based on functional studi es and its occurrence in individuals with this disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

From University of Washington Center for Mendelian Genomics, University of Washington, SCV000993477.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024